In adults with anxiety and Attention Deficit Hyperactivity Disorder (ADHD), which condition should be treated first?

Treatment Sequencing for Adults with Comorbid ADHD and Anxiety

Direct Answer

Treat ADHD first with stimulants in most adults with comorbid ADHD and anxiety, as stimulants improve both ADHD symptoms and frequently reduce anxiety symptoms without additional intervention. 1, 2

---

Primary Treatment Algorithm

Step 1: Initiate Stimulant Treatment for ADHD

• Start with extended-release stimulant formulations (methylphenidate or lisdexamfetamine) as first-line treatment, even when anxiety is present 1, 2
• Stimulants offer rapid onset of action (days to weeks), allowing quick assessment of whether both ADHD and anxiety symptoms improve 1, 2
• The outdated concern that stimulants worsen anxiety has been disproven—patients with comorbid anxiety actually show better treatment responses to stimulants than those without anxiety 1, 2
• Extended-release formulations provide all-day symptom control and minimize rebound effects that could exacerbate anxiety 1, 2

Step 2: Evaluate Response After 2-4 Weeks

If both ADHD and anxiety improve:

• Continue stimulant monotherapy without modification 1
• No additional treatment is necessary 1

If ADHD improves but anxiety persists:

• Add cognitive behavioral therapy (CBT) targeting anxiety symptoms 1
• If anxiety remains problematic despite CBT, add an SSRI (sertraline, escitalopram, or citalopram preferred due to lower drug interaction potential) 1, 2
• Start SSRIs at subtherapeutic "test" doses initially, as SSRIs can paradoxically cause anxiety or agitation in the first 1-2 weeks 1
• Titrate shorter half-life SSRIs at 1-2 week intervals; longer half-life SSRIs at 3-4 week intervals 1

If stimulants are ineffective or poorly tolerated:

• Consider alpha-2 agonists (guanfacine or clonidine) as adjunctive treatment, which address both ADHD symptoms and emotional dysregulation 1, 2

---

Alternative First-Line Option: Atomoxetine

Consider atomoxetine instead of stimulants when:

• Severe anxiety is present with significant avoidance behaviors or distress 1, 2
• Active substance use disorder exists (atomoxetine lacks abuse potential) 1, 3
• Pre-existing sleep disorders are present 1, 2
• Stimulant non-response or intolerance has occurred 1, 2

Atomoxetine advantages:

• Provides "around-the-clock" effects without rebound 1, 2
• FDA labeling confirms it does not worsen anxiety in adults with ADHD and comorbid social anxiety disorder (16-week trial, n=442) 3
• Treats both ADHD and anxiety symptoms effectively 4

Atomoxetine monitoring requirements:

• Monitor appetite and weight 1
• Monitor for suicidal ideation (black box warning) 1, 3
• If combining with SSRIs that inhibit CYP2D6 (fluoxetine, paroxetine), dose adjustment of atomoxetine may be necessary 1

---

Exception: When to Treat Anxiety First

Treat anxiety first only if:

• Anxiety presents with very severe symptoms including major avoidance behaviors, significant functional impairment, or severe distress that prevents engagement in ADHD treatment 1
• Once anxiety is stabilized with SSRIs and/or CBT, re-evaluate ADHD symptoms and initiate appropriate ADHD treatment 1

This approach is supported by limited case report evidence suggesting that treating anxiety until clear symptom reduction occurs may be more appropriate than treating ADHD alone in severe anxiety cases 5

---

Critical Safety Considerations

When Combining Stimulants with SSRIs

• Exercise caution due to serotonin syndrome risk when combining SSRIs with stimulants 2
• Start SSRIs at low doses and increase slowly 2
• Monitor especially in the first 24-48 hours after dosage changes 2
• Escitalopram and citalopram have the least CYP450 enzyme effects and lowest drug interaction propensity 1, 2
• Monitor for suicidal ideation, clinical worsening, and unusual behavioral changes, particularly when initiating SSRIs 1

Avoiding Common Pitfalls

• Do not start both medications simultaneously—this prevents determining which medication is responsible for therapeutic effects or adverse effects 1
• Do not assume anxiety is a contraindication to stimulants—this outdated belief deprives patients of the most effective treatment 1
• Do not use bupropion as first-line—it is explicitly labeled as second-line at best for ADHD with limited evidence and requires weeks to months for full effect 1
• Do not combine bupropion with stimulants without careful consideration—there is no safety data for this combination 1

---

Monitoring Requirements

• Monitor height, weight, blood pressure, and pulse under stimulant treatment 1
• Use standardized symptom rating scales to systematically assess treatment response for both ADHD and anxiety 1
• Assess for initial SSRI-induced anxiety or agitation, which typically emerges in the first 1-2 weeks 1

---

Adjunctive Psychotherapy

• Add CBT to the medication regimen if anxiety remains problematic despite adequate SSRI dosing, as combination treatment (CBT plus SSRI) shows superior outcomes for anxiety disorders including improved global function, response to treatment, and remission rates 1, 4, 6
• CBT is considered superior to medication alone for comorbid ADHD and anxiety 4, 6